Close

AstraZeneca (AZN) Reports Selumetinib Phase 3 Missed Primary Endpoint in NSCLC (ARRY)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. NVDA
4. PPG
5. HDFCB:IN
6. HDB
7. META
8. WIT
9. HDFCAMC:IN
10. CRM


Go back to AstraZeneca (AZN) Reports Selumetinib Phase 3 Missed Primary Endpoint in NSCLC (ARRY)